These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24857693)

  • 1. How best to interpret mixed human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia lesions.
    Callegari ET; Tabrizi SN; Pyman J; Saville M; Cornall AM; Brotherton JM; Garland SM
    Vaccine; 2014 Jul; 32(32):4082-8. PubMed ID: 24857693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
    Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
    Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One virus, one lesion--individual components of CIN lesions contain a specific HPV type.
    Quint W; Jenkins D; Molijn A; Struijk L; van de Sandt M; Doorbar J; Mols J; Van Hoof C; Hardt K; Struyf F; Colau B
    J Pathol; 2012 May; 227(1):62-71. PubMed ID: 22127961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?
    van der Marel J; Berkhof J; Ordi J; Torné A; Del Pino M; van Baars R; Schiffman M; Wentzensen N; Jenkins D; Quint WG
    Am J Surg Pathol; 2015 Apr; 39(4):496-504. PubMed ID: 25353286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
    Cleveland AA; Gargano JW; Park IU; Griffin MR; Niccolai LM; Powell M; Bennett NM; Saadeh K; Pemmaraju M; Higgins K; Ehlers S; Scahill M; Johnson Jones ML; Querec T; Markowitz LE; Unger ER;
    Int J Cancer; 2020 Feb; 146(3):810-818. PubMed ID: 30980692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.
    Leeman A; Ebisch RMF; Kasius A; Bosgraaf RP; Jenkins D; van de Sandt MM; de Strooper LMA; Heideman DAM; Snijders PJF; Massuger LFAG; Bekkers RLM; Meijer CJLM; van Kemenade FJ; Quint WGV; Melchers WJG
    Gynecol Oncol; 2018 Nov; 151(2):311-318. PubMed ID: 30219239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of attribution algorithms for resolving CIN3-related HPV genotype prevalence in mixed-genotype biopsy specimens using laser capture microdissection as the reference standard.
    Cornall AM; Brotherton JML; Callegari ET; Tan FH; Saville M; Pyman J; Phillips S; Malloy MJ; Tabrizi SN; Garland SM;
    Vaccine; 2020 Sep; 38(40):6312-6319. PubMed ID: 32736939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
    Lehtinen M; Paavonen J; Wheeler CM; Jaisamrarn U; Garland SM; Castellsagué X; Skinner SR; Apter D; Naud P; Salmerón J; Chow SN; Kitchener H; Teixeira JC; Hedrick J; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; De Carvalho NS; Germar MJ; Peters K; Mindel A; De Sutter P; Bosch FX; David MP; Descamps D; Struyf F; Dubin G;
    Lancet Oncol; 2012 Jan; 13(1):89-99. PubMed ID: 22075171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of HPV genotypes causing cervical precancer using tissue-based genotyping.
    Venetianer R; Clarke MA; van der Marel J; Tota J; Schiffman M; Dunn ST; Walker J; Zuna R; Quint W; Wentzensen N
    Int J Cancer; 2020 May; 146(10):2836-2844. PubMed ID: 32037535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.
    Quint KD; de Koning MN; van Doorn LJ; Quint WG; Pirog EC
    Gynecol Oncol; 2010 May; 117(2):297-301. PubMed ID: 20207397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
    Perez S; Iñarrea A; Pérez-Tanoira R; Gil M; López-Díez E; Valenzuela O; Porto M; Alberte-Lista L; Peteiro-Cancelo MA; Treinta A; Carballo R; Reboredo MC; Alvarez-Argüelles ME; Purriños MJ
    Virol J; 2017 Nov; 14(1):214. PubMed ID: 29110680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.
    Sehnal B; Dusek L; Cibula D; Zima T; Halaska M; Driak D; Slama J
    J Clin Virol; 2014 Jan; 59(1):18-23. PubMed ID: 24315797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.
    Joura EA; Ault KA; Bosch FX; Brown D; Cuzick J; Ferris D; Garland SM; Giuliano AR; Hernandez-Avila M; Huh W; Iversen OE; Kjaer SK; Luna J; Miller D; Monsonego J; Munoz N; Myers E; Paavonen J; Pitisuttithum P; Steben M; Wheeler CM; Perez G; Saah A; Luxembourg A; Sings HL; Velicer C
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1997-2008. PubMed ID: 25274978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact.
    Pérez-Castro S; Lorenzo-Mahía Y; Iñarrea Fernández A; Lamas-González MJ; Sarán-Díez MT; Rubio-Alarcón J; Reboredo-Reboredo MC; Mosteiro-Lobato S; López-Miragaya I; Torres-Piñón J; Melón-García S
    Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):479-85. PubMed ID: 24274937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of human papillomavirus genotypes among patients with cervical cancer and cervical intraepithelial neoplasia 3 in Israel.
    Bassal R; Rosin LS; Schvimer M; Schejter E; Ozeryansky B; Kulik S; Bachar R; Shapira H; Sandbank J; Cohen D; Keinan-Boker L
    J Low Genit Tract Dis; 2015 Apr; 19(2):161-4. PubMed ID: 25105719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Papillomavirus (HPV) Genotypes in Condylomas, Intraepithelial Neoplasia, and Invasive Carcinoma of the Penis Using Laser Capture Microdissection (LCM)-PCR: A Study of 191 Lesions in 43 Patients.
    Fernández-Nestosa MJ; Guimerà N; Sanchez DF; Cañete-Portillo S; Velazquez EF; Jenkins D; Quint W; Cubilla AL
    Am J Surg Pathol; 2017 Jun; 41(6):820-832. PubMed ID: 28486384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
    Pista A; de Oliveira CF; Lopes C; Cunha MJ;
    Int J Gynecol Cancer; 2013 Mar; 23(3):500-6. PubMed ID: 23392401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3.
    Litjens RJ; Van de Vijver KK; Hopman AH; Ummelen MI; Speel EJ; Sastrowijoto SH; Van Gorp T; Slangen BF; Kruitwagen RF; Krüse AJ
    Hum Pathol; 2014 Feb; 45(2):221-6. PubMed ID: 24439220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
    Castle PE; Schiffman M; Wheeler CM; Wentzensen N; Gravitt PE
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1675-81. PubMed ID: 20615885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.